<code id='6B03A740FF'></code><style id='6B03A740FF'></style>
    • <acronym id='6B03A740FF'></acronym>
      <center id='6B03A740FF'><center id='6B03A740FF'><tfoot id='6B03A740FF'></tfoot></center><abbr id='6B03A740FF'><dir id='6B03A740FF'><tfoot id='6B03A740FF'></tfoot><noframes id='6B03A740FF'>

    • <optgroup id='6B03A740FF'><strike id='6B03A740FF'><sup id='6B03A740FF'></sup></strike><code id='6B03A740FF'></code></optgroup>
        1. <b id='6B03A740FF'><label id='6B03A740FF'><select id='6B03A740FF'><dt id='6B03A740FF'><span id='6B03A740FF'></span></dt></select></label></b><u id='6B03A740FF'></u>
          <i id='6B03A740FF'><strike id='6B03A740FF'><tt id='6B03A740FF'><pre id='6B03A740FF'></pre></tt></strike></i>

          explore

          explore

          author:entertainment    Page View:158
          Illustration of a hospital bed with a spotlight above and money below. -- health tech coverage from STAT
          Adobe

          General Catalyst’s plan to take over a hospital in the coming months could be the first of many such deals, driven by financially strained hospitals looking for saviors, and venture capitalists convinced that they have the technology solutions for fixing the health care sector’s vexing problems.

          The venture firm announced plans in October to acquire a health system and then use it as a proving ground for technology that its portfolio companies sell, including generative artificial intelligence-powered solutions applied to health care problems. The move — a result of industry-wide frustration with health systems’ risk aversion and hesitation to adopt new technology — also comes at a time when health tech startups that raised millions of venture dollars during the pandemic’s early stages are now scrambling to find customers.

          advertisement

          Given workforce shortages, clinician burnout, rising drug costs, and a surging aging population, “it’s not that big a leap to say that more such purchases are going to occur,” said Robert Klitzman, a Columbia psychiatry professor and director of its bioethics masters program. “Hospitals are in a very tough spot,” he said, adding, “There may be hospitals that think, ‘Oh, great, someone wants to buy us.’”

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          DIEP, the 'gold standard' of breast reconstruction, is under threat
          DIEP, the 'gold standard' of breast reconstruction, is under threat

          AdobeIn1983,Iflewhomefromcollegetobewithmymotherasshewokeupfromamastectomy.Sheoptedoutofbreastrecons

          read more
          Biden's order seeks to regulate AI risk without stifling innovation
          Biden's order seeks to regulate AI risk without stifling innovation

          AdobePresidentBidenorderedthenation’sleadinghealthagenciesonMondaytodevelopaplanforregulatingartific

          read more
          Dobbs anniversary: the lost opportunity of abortion as health care
          Dobbs anniversary: the lost opportunity of abortion as health care

          NathanHoward/GettyImagesReflectingonthisfirstanniversaryoftheSupremeCourt’sdecisioninDobbstooverturn

          read more

          The FDA weighs the risks of candy

          AdobeWASHINGTON—M&Ms,Reese’s,gummybears,andevencottoncandymadeanappearanceattheFoodandDrugAdmini